Skip to content

An Integrated Triangle-Stratified Shared Care Model Improves Hemoglobin Control in Hemodialysis: A 24-Month Prospective Study

Application of Triangle Stratified Grading Combined with "Doctor-Nurse Shared Care" Model in Anemia Management for Maintenance Hemodialysis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120640
Enrollment
Unknown
Registered
2026-03-17
Start date
2024-02-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Anemia

Interventions

Post-intervention group:During the intervention phase (February 2024 to February 2025), the "Triangle-Stratified Grading + Shared Doctor-Nurse Care" model was implemented: dynamic stratification based
Pre-intervention group:The pre-intervention phase (February 2023 to February 2024) consisted of routine management, i.e., anemia management according to clinical routine pathways, without any research

Sponsors

The Third Hospital of Mianyang, Sichuan Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. age >=18 years; 2. receiving regular MHD (two to three times/week) for >3 months; 3. clinically stable condition; 4. voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1. severe malnutrition; 2. history of malignancy; 3. acute or chronic hemorrhagic disorders or blood transfusion within the past 3 months; 4. severe infectious diseases within the past 2 months or poorly controlled chronic inflammatory conditions; 5. unstable angina, myocardial infarction, coronary intervention, or stroke within the past 3 months; 6. anemia secondary to nonrenal causes (e.g., hematologic malignancies, coagulopathies, hemolytic anemia); 7. planned kidney transplantation or major surgery during the study period; 8. poorly controlled hypertension (systolic blood pressure >180 mm Hg or diastolic blood pressure >100 mm Hg).

Design outcomes

Primary

MeasureTime frame
Hemoglobin standard-reaching rate;Hemoglobin levels;

Secondary

MeasureTime frame
Erythropoietin dosage;Serum Ferritin;Albumin;

Countries

China

Contacts

Public ContactTing Wang

The Third Hospital of Mianyang, Sichuan Mental Health Center

1608773981@qq.com+86 133 5001 4485

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026